Pricing and Adoption of Oncology Biosimilars, Flu Immunity After Immunization, Psilocybin Use After Decriminalization, and more episode artwork

EPISODE · Mar 13, 2026 · 9 MIN

Pricing and Adoption of Oncology Biosimilars, Flu Immunity After Immunization, Psilocybin Use After Decriminalization, and more

from JAMA Editors' Summary

Editor's Summary by Linda Brubaker, MD, and Preeti Malani, MD, MSJ, Deputy Editors of JAMA, the Journal of the American Medical Association, for articles published from March 7-13, 2026.

Episode metadata supplied by the publisher feed · Published Mar 13, 2026

Embed this episode

NOW PLAYING

Pricing and Adoption of Oncology Biosimilars, Flu Immunity After Immunization, Psilocybin Use After Decriminalization, and more

0:00 9:13

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JAMA Editors' Summary?

This episode is 9 minutes long.

When was this JAMA Editors' Summary episode published?

This episode was published on March 13, 2026.

Can I download this JAMA Editors' Summary episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!